市場調査レポート
商品コード
1371951
感染管理市場の2030年までの予測:製品・サービス別、エンドユーザー別、地域別の世界分析Infection Control Market Forecasts to 2030 - Global Analysis By Product & Service, By End User and By Geography |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
感染管理市場の2030年までの予測:製品・サービス別、エンドユーザー別、地域別の世界分析 |
出版日: 2023年10月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2~3営業日
|
Stratistics MRCによると、世界の感染管理市場は2023年に2,379億6,000万米ドルを占め、予測期間中にCAGR8.7%で成長し、2030年までに4,267億米ドルに達すると予測されています。
感染管理とは、細菌、ウイルス、真菌、寄生虫などの感染因子の拡散を防ぐことを目的とした一連の実践と対策を指し、ヘルスケア環境、地域環境、または感染伝播が起こり得るその他の状況において行われます。感染管理の主な目的は、個人を感染症から守り、人から人への感染拡大を防ぐことです。
WHOが発表した統計によると、急性呼吸器疾患(ARDs)は世界的に死亡率の高い主な原因の一つです。ARDsが原因で毎年約400万人が死亡しています。
毎年、安全でない不十分な医療によって、何百万人もの患者が負傷または死亡しています。ヘルスケアに関連する数多くの医療処置やリスクが、不適切なケアによる危害の負担を著しく増大させています。世界保健機関(WHO)によると、安全でない外科処置による合併症は、患者の最大25%に影響を及ぼす可能性があります。高所得国および中低所得国の病院では、患者100人のうち7~10人がヘルスケア関連感染に苦しんでいます。また、米国疾病管理センター(CDC)は、HAIは170万人の感染に加え、年間99,000人の死亡の原因になっていると考えられると指摘しています。病院感染症は増加しており、これが感染管理製品への需要を煽り、市場拡大を加速させています。
現在市販されている化学消毒剤の大半には毒性があります。消毒薬の誤用は、消毒薬にさらされた患者や環境を危険にさらす可能性があります。これらの消毒剤を殺虫剤に分類している環境保護庁(EPA)は、米国内で販売されるすべての消毒剤の登録を義務付けています。さらに、メーカーは現在、pH中性の第4級、ブチルフリー、過酸化水素をベースとした消毒剤など、よりクリーンで環境にやさしく、人の目へのダメージが少ない消毒剤の開発を迫られています。こうした要因が市場拡大を阻害しています。
感染管理市場は、未開拓の機会、ヘルスケア部門のインフラ整備、製薬・医療機器企業の増加、感染管理製品に対する消費者需要の高まりによって拡大すると予測されます。新興国では、より洗練された製造システムに対する需要の高まりや、ヘルスケア・インフラのアップグレードに向けた政府の大規模な投資の結果、ヘルスケア・セクターが拡大しています。アジア諸国では、豊富な資源を背景に、医薬品研究や医療機器産業が成長しています。これらすべての要素を組み合わせることで、予測期間中に市場拡大のさまざまな機会がもたらされると予想されます。
ヘルスケア予算の制約やコスト重視の慣行は、高度な感染管理技術への投資を制限する可能性があります。市場の飽和とサプライヤー間の激しい競争は、価格に下落圧力をかけ、収益性に影響を与える可能性があります。さらに、さまざまな地域における規制の変更やコンプライアンス上の課題も脅威となり、企業は複雑な基準を乗り越える必要があるため、市場の成長はさらに抑制されます。
COVID-19の大流行は、世界の感染管理の実践に大きな影響を与えました。厳格な感染管理対策の重要性に対する認識が高まり、個人用保護具(PPE)、衛生用品、ヘルスケア用消毒剤の需要増につながっています。病院やヘルスケア施設は、病気の感染を防ぐためにより厳格なプロトコルを導入しています。さらに、パンデミックは新しい感染管理技術や戦略の開発と採用を加速させました。このパンデミックは、ヘルスケアや公共空間における感染管理への強固な備えと投資の必要性を改めて認識させるものであり、この期間中に進化する課題に対応するため、業界をさらに再形成しています。
病院分野は市場貢献度が最も高く、予測期間中最大の市場シェアを占めると予想されます。病院には、訓練を受けた医療従事者、看護要員、専門機器を備えたヘルスケア施設があります。高いレベルの感染予防を確保するための政府のイニシアチブの増加、最先端の感染管理技術を備えた病院の増加、病院で行われる外科手術の増加、一人暮らしの高齢者の増加などが、このセグメントの拡大に寄与しています。
予測期間中、滅菌製品・サービス分野のCAGRが最も高くなると予測されます。感染症が病院やその他のヘルスケア施設全体に広がるのを防ぐには、滅菌が極めて重要です。世界保健機関(WHO)によれば、感染症は毎年1,700万人の命を奪っており、過去20年間に少なくとも30種類の新感染症が発生したと推定されています。予測期間中、手術率の上昇、感染症の蔓延、ヘルスケア分野の拡大が市場拡大に拍車をかけると予想されます。
予測期間中、北米は感染管理市場における主導権を維持すると予測されます。市場開拓に影響を与える重要な要因としては、同地域における大手市場プレイヤーの存在、整備されたヘルスケアインフラ、感染管理技術の普及などが挙げられます。同地域のシェアが大きいのは、主要市場企業が製品ポートフォリオと感染管理能力を拡大するために採用した戦略的提携の数が一貫して多いためと考えられます。さらに、この地域全体にプレゼンスを拡大しようとする既存企業の取り組みが活発化していることも、北米の圧倒的な市場シェアの要因となっています。
アジア太平洋地域は、アウトソーシング企業の存在感の高まり、医療支出の増加、この地域全体のヘルスケア基準とインフラのかつてない進化により、予測期間を通じて最も高いCAGRを示すと予想されます。感染管理基準の改善に注力するさまざまな任意団体や政府機関の存在も、アジア太平洋地域の成長に寄与する重要な要因の1つです。さらに、新興経済諸国の既存市場企業がアジア太平洋地域の企業にアウトソーシングする傾向が強まっていることも、市場の成長を促す重要な要因となっています。
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
According to Stratistics MRC, the Global Infection Control Market is accounted for $237.96 billion in 2023 and is expected to reach $426.70 billion by 2030 growing at a CAGR of 8.7% during the forecast period. Infection control refers to a set of practices and measures aimed at preventing the spread of infectious agents, such as bacteria, viruses, fungi, and parasites, within healthcare settings, community environments, or other contexts where the transmission of infections can occur. The primary goals of infection control are to protect individuals from acquiring infections and to prevent the spread of infections from one person to another.
According to the statistics published by WHO, Acute Respiratory Diseases (ARDs) is one of the major causes of high mortality rates globally. Approximately 4.0 million deaths occur every year due to ARDs.
Every year, unsafe and inadequate medical care results in the injuries or deaths of millions of patients. Numerous medical procedures and risks associated with healthcare significantly increase the burden of harm from inadequate care. According to the World Health Organization, complications from unsafe surgical procedures can affect up to 25% of patients. 7 to 10 out of every 100 patients in hospitals in high-income and low- and middle-income countries suffer from healthcare-associated infections. The Centers for Disease Control (CDC) also note that HAIs are thought to be responsible for 99,000 fatalities annually in addition to 1.7 million infections. Hospital infections are increasing, which has fueled demand for infection control products and accelerated market expansion.
The majority of chemical disinfectants currently available on the market have toxic properties. Misuse of disinfectants can put patients exposed to them and the environment in danger. The Environmental Protection Agency (EPA), which classifies these disinfection products as pesticides, requires registration for all disinfectants sold in the US. Moreover, manufacturers are currently under pressure to develop cleaner, more environmentally friendly disinfectants that are less damaging to people's eyes, like pH-neutral quaternary, butyl-free, and disinfectants based on hydrogen peroxide. Such factors impede market expansion.
The market for infection control is predicted to grow as a result of untapped opportunities, improved infrastructure for the healthcare sector, an increase in the number of pharmaceutical and medical device companies, and rising consumer demand for infection control products. The healthcare sector is expanding in emerging economies as a result of the rise in demand for more sophisticated manufacturing systems and significant government investments to upgrade healthcare infrastructure. Asian countries have experienced growth in the pharmaceutical research and medical device industries as a result of the abundance of resources available. Combining all these elements is anticipated to present a variety of opportunities for market expansion during the forecast period.
Healthcare budget constraints and cost-conscious practices may limit investments in advanced infection control technologies. Market saturation and intense competition among suppliers could exert downward pressure on prices, potentially impacting profitability. Additionally, regulatory changes and compliance challenges in different regions also pose a threat, requiring companies to navigate complex standards, which further restrains market growth.
The COVID-19 pandemic has profoundly impacted infection control practices worldwide. It has heightened awareness about the importance of stringent infection control measures, leading to increased demand for personal protective equipment (PPE), sanitation products, and healthcare disinfectants. Hospitals and healthcare facilities have implemented more rigorous protocols to prevent disease transmission. Additionally, the pandemic has accelerated the development and adoption of novel infection control technologies and strategies. It serves as a stark reminder of the need for robust preparedness and investment in infection control in healthcare and public spaces, further reshaping the industry to meet evolving challenges during this period.
The hospitals segment contributes the most to the market and is anticipated to have the largest market share during the forecast period. Hospitals contain healthcare facilities with trained medical personnel, nursing personnel, and specialized equipment. Increased government initiatives to ensure high levels of infection prevention, an increase in hospitals with cutting-edge infection control techniques, an increase in the number of surgical procedures carried out in hospitals, and an increase in the number of elderly people living alone are all factors contributing to the segment's expansion.
During the anticipated timeframe, the segment for sterilization products and services is predicted to have the highest CAGR. Antibiotics might not be able to stop such a widespread attack, so sterilization is crucial to preventing infectious diseases from spreading throughout hospitals or other healthcare facilities. Infectious diseases claim the lives of 17 million people each year, according to the World Health Organization (WHO), which estimates that at least 30 new diseases have emerged in the last 20 years. Over the course of the forecast period, it is also anticipated that rising surgical rates, an increase in the prevalence of infectious diseases, and expansion in the healthcare sector will spur market expansion.
During the forecast period, North America is anticipated to maintain its leadership in the infection control market. Some important factors influencing market growth include the presence of major market players in the region, a well-developed healthcare infrastructure, and the widespread use of infection control technologies. The larger share seized by this region is thought to be due to a consistent number of strategic collaborations adopted by key market players to expand their product portfolio and infection control capabilities. Additionally, the established businesses' increased efforts to expand their presence throughout this region are to blame for North America's dominant market share.
Asia Pacific region is expected to exhibit the highest CAGR throughout the forecast period owing to the growing presence of outsourcing organizations, growing healthcare expenditure, and the unprecedented evolution of healthcare standards and infrastructure across this region. The presence of various voluntary and government organizations focused on improving infection control standards is also one of the significant factors contributing to the growth of the Asia-Pacific region. Additionally, the increasing trend of outsourcing by established market players in developed economies to companies in the Asia-Pacific region also serves as a key growth-impelling factor for the market.
Some of the key players in Infection Control Market include: Ecolab Inc., Fortive Corporation (Advanced Sterilization Products), Genitge Ab, Matachana Group, Miele Group. (Steelco), MMM Group, Sotera Health Inc and Steris PLC.
In September 2023, 3M reported that both the split-off exchange offer for 3M common stock and the closure of the merger of Garden SpinCo Corporation ("SpinCo"), the 3M subsidiary owning the food safety business, with a subsidiary of Neogen Corporation had been completed ("Neogen").
In June 2023, Social care nurses in Scotland can now access the latest infection prevention and control (IPC) guidance in their pocket thanks to a new app launched this week. It was developed in partnership between the Scottish Social Services Council (SSSC), NHS Education for Scotland (NES) and the Digital Health & Care Innovation Centre (DHI).
In May 2023, Getinge announced an agreement to acquire High Purity New England, Inc., a leading US-based company in the fast-growing areas of custom single-use solutions for bioprocessing applications. Getinge has paid approximately SEK 1,330 M (USD 120 M) in cash on closing, on a cash and debt free basis for 100 % of the shares. In addition, a maximum earn out of approximately SEK 1,880 M (USD 170 M) can be paid out during 2024 - 2026 if agreed net revenue performance milestones are achieved in 2023 - 2025.